3-Year Supporting Data on TAVI in Low-Risk Patients: EVOLUT

Published Date: 08 Mar 2023

3-year results show that patients who underwent low-risk aortic valve replacement continue to report lower rates of all-cause mortality and stroke with TAVI compared to surgery

Read Full News

Latest News

Screen All With Diabetes for Peripheral Vascular Disease?

Two speakers debated this question at the recent American Diabetes Association Scientific Sessions.

5 Heat Safety Tips for Patients With Heart Disease

High temperatures can quickly destabilize patients with cardiovascular disease, making clear, office-ready advice especially important during summer.

Women and Diabetes: Is Care Keeping Pace With Biology?

Hormonal changes throughout a woman’s life influence insulin needs, glucose regulation, and cardiovascular risk, highlighting the need for individualized diabetes care.

Study Probes Absolute Risk for ION With GLP-1 Agents

In patients with type 2 diabetes, GLP-1 RAs may be associated with a higher incidence of ischemic optic neuropathy than other medications, claims data show.

Simplified Score Improves Legionella Detection

Among patients with community-acquired pneumonia, a simplified five-predictor SwissLEGIO score rules out Legionnaires disease with high sensitivity, outperforming a widely cited score.

Fatty Pancreas Linked to Risk for T2D and CKD

Moderate-to-severe fatty pancreas is independently linked to a higher risk for incident type 2 diabetes and chronic kidney disease.

Todays Updates

Race, Geography Linked to Gaps in Prostate Cancer Care

A US government study finds racial disparities in care and a complicated relationship between distance to major cancer centers and patients’ treatment and outcomes.

Todays Updates

Race, Geography Linked to Gaps in Prostate Cancer Care

A US government study finds racial disparities in care and a complicated relationship between distance to major cancer centers and patients’ treatment and outcomes.

Latest News

Two speakers debated this question at the recent American Diabetes Association Scientific Sessions.

High temperatures can quickly destabilize patients with cardiovascular disease, making clear, office-ready advice especially important during summer.

Hormonal changes throughout a woman’s life influence insulin needs, glucose regulation, and cardiovascular risk, highlighting the need for individualized diabetes care.

In patients with type 2 diabetes, GLP-1 RAs may be associated with a higher incidence of ischemic optic neuropathy than other medications, claims data show.

Among patients with community-acquired pneumonia, a simplified five-predictor SwissLEGIO score rules out Legionnaires disease with high sensitivity, outperforming a widely cited score.

Moderate-to-severe fatty pancreas is independently linked to a higher risk for incident type 2 diabetes and chronic kidney disease.

News All Time

Rising Medication Use May Drive Lower BP, Cholesterol Risks

The decreases in blood pressure and cholesterol in higher income countries are mainly observed in older patients with obesity; obesity’s other effects remain a concern.

Self-Expanding Valves Shine in Small Aortic Annuli

In mostly women with small aortic annuli, self-expanding valves maintained superior hemodynamics and far lower valve dysfunction than balloon-expandable devices at 3 years.

TAVR Matches Surgical Valve Durability at 7 Years

Data on valve durability with transcatheter aortic valve replacement are reassuring at 7 years, with implications for lifetime management in younger patients with aortic stenosis.

Smartwatch-Based Algorithm May Predict Worsening HF

A smartwatch-based AI algorithm shows high accuracy in predicting rises in levels of N terminal pro-B type natriuretic peptide and may provide early alerts for worsening heart failure, a study finds.

Secret Shopper Study Warns About Online GLP-1 Sellers

Two-thirds of websites did not require clinician interaction before a prescription

Case Report: Cannabis and Compulsive Showering

An unexpected effect of chronic marijuana use

Chronically Short Sleep May Lead to Weight Gain in Adults With Heart Risks

Pooled analysis of two trials shows impact when losing just 1.5 hours a night

When Endurance Training Can Be Deadly for Older Athletes

This case shows the danger of one asymptomatic condition in particular

Cardiologist Runs for Mayor; PCSK9 Inhibitor Price Drops; Pregnancy OK After AVR?

Recent developments of interest in cardiovascular medicine

ASPECTS Fails to Reflect Ceiling for Endovascular Stroke Therapy Benefit

Quantitative volumetry better avoids futile reperfusion, per a nationwide study

Chronic Kidney Disease Increasingly Driven By Diabetes

Despite treatment advances, kidney disease burden remained unchanged over the past decade

Giant Cell Arteritis: Are Steroids Overused?

Chronic dosing at levels high enough to cause adverse effects remains common, French data show

A Better Idea of When Mild HCM Is Likely to Go Downhill Fast

— Natural history study probes predictors of worsening in mild disease

Lower Right Heart Reserve Linked to Worse Shunt Outcomes

In patients with heart failure, a lower TAPSE/PASP ratio is linked to higher rates of cardiovascular death or heart failure hospitalisation after interatrial shunting.

CMS Proposes TAVR Coverage Framework

Treating patients with symptomatic aortic stenosis does not require collecting further evidence.

Dapagliflozin Cuts Heart Risk in T2D With Advanced Fibrosis

Dapagliflozin can reduce the risk for major adverse cardiovascular events in patients with T2D at a high risk for advanced liver fibrosis, according to a retrospective study.

Recommended News For You

Who Bears the Cost of "Forever Chemical" Cleanup?

Advanced imaging, targeted therapy help men with prostate cancer safely defer surgery and radiation therapy

Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.

In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.

Pancreatic cancer RNA vaccine shows durable T cell immunity

Nearly 6 Million Deaths From Five Major Cancer Types Averted Since 1975

Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results

Recommended Articles For You

The Importance of Having a Quick and Effective Heparin Antidote  

Integrated Insights in Hematology and Quality Improvement 

Understanding Odontogenic Keratocyst: Symptoms, Causes, and Treatments from Dental Experts 

Beating Cancer Fatigue The Most Effective Exercise Strategies for Breast Cancer Survivors 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Examines Office-Based Transperineal Prostate Biopsies Methodology.

2.

Patients value communication skills from cancer surgeons across six key areas, according to research

3.

Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients

4.

Underprescribed for Alcohol Use Disorder is pharmacotherapy.

5.

A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma

1.

Transfusing the Future: Exploring the Possibilities of Blood Transfusions

2.

Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications

3.

Iron Deficiency Anemia: Challenges in Diagnosis and Treatment

4.

Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers

5.

The Potential of Amifostine in Cancer Treatment: A Revolutionary Breakthrough

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

2.

Current Scenario of Cancer- Palliative Care to Close the Care Gap

3.

The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift

4.

Updates on the First Line Management of ALK+ NSCLC

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot